Bio-Rad Laboratories (BIO) Capital Expenditures Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.95% |
| Dec 31, 2025 | -1.29% |
| Sep 30, 2025 | 9.67% |
| Jun 30, 2025 | 20.33% |
| Mar 31, 2025 | 9.76% |
| Dec 31, 2024 | 14.71% |
| Sep 30, 2024 | 5.27% |
| Jun 30, 2024 | 13.75% |
| Mar 31, 2024 | 11.21% |
| Dec 31, 2023 | -20.10% |
| Jun 30, 2023 | 26.77% |
| Mar 31, 2023 | 5.62% |
| Dec 31, 2022 | 5.96% |
| Sep 30, 2022 | 6.30% |
| Jun 30, 2022 | 32.07% |
| Mar 31, 2022 | -14.77% |
| Dec 31, 2021 | -16.86% |
| Jun 30, 2021 | 34.67% |
| Mar 31, 2021 | 15.20% |
| Dec 31, 2020 | 11.80% |
| Sep 30, 2020 | -24.50% |
| Jun 30, 2020 | 22.33% |
| Mar 31, 2020 | -4.43% |
| Dec 31, 2019 | 85.55% |
| Sep 30, 2019 | 80.23% |
| Jun 30, 2019 | 2.72% |
| Mar 31, 2019 | 0.91% |
| Dec 31, 2018 | 36.18% |
| Jun 30, 2018 | -25.47% |
| Mar 31, 2018 | -4.43% |
| Dec 31, 2017 | -3.09% |
| Sep 30, 2017 | -11.14% |
| Jun 30, 2017 | -17.18% |
| Mar 31, 2017 | 16.24% |
| Dec 31, 2016 | 31.73% |
| Jun 30, 2016 | -19.03% |
| Mar 31, 2016 | -11.56% |
| Dec 31, 2015 | -2.76% |
| Sep 30, 2015 | 31.90% |
| Jun 30, 2015 | -19.81% |
| Mar 31, 2015 | 29.56% |
| Dec 31, 2014 | -61.56% |
| Sep 30, 2014 | 16.05% |